Cargando…
Combination of intensity modulated radiotherapy followed treatment with p38 MAPK activation inhibitor inhibits the proliferation of MCF-7 breast cancer cells
The present study was aimed to investigate the effect of intensity modulated radiotherapy (IMRT) followed by treatment with inhibitor for p38 MAPK, SB203580 on the rate of proliferation in drug resistant MCF-7 breast cancer cells. Interestingly, the results from immuno histochemistry and western blo...
Autores principales: | Zhao, Jianhua, Cheng, Guanxun, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775077/ https://www.ncbi.nlm.nih.gov/pubmed/29379349 http://dx.doi.org/10.1016/j.sjbs.2017.01.061 |
Ejemplares similares
-
P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023) -
Inhibition of LPS-Induced Activation of Coagulation by p38 MAPK Inhibitor
por: Koch, Lutz, et al.
Publicado: (2012) -
Morus alba Leaf Lectin (MLL) Sensitizes MCF-7 Cells to Anoikis by Inhibiting Fibronectin Mediated Integrin-FAK Signaling through Ras and Activation of P(38) MAPK
por: Saranya, Jayaram, et al.
Publicado: (2017) -
Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF-7 cells
por: Lin, Kehao, et al.
Publicado: (2021) -
HOXB7-S3 inhibits the proliferation and invasion of MCF-7 human breast cancer cells
por: MA, RUI, et al.
Publicado: (2015)